Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2008
10/22/2008EP1981847A1 Secondary amines as renin inhibitors
10/22/2008EP1981845A2 Sulfonamide derivatives to treat infection with hepatitis c virus
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101289418A Miglitol crystal and method for preparing same
10/22/2008CN100427480C Process for preparing argatroban hydrate
10/21/2008US7439396 Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
10/21/2008US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/21/2008US7439366 Phenacylamine derivatives, process for their production and pesticides containing them
10/21/2008US7439365 Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
10/21/2008US7439362 For treatment of acne, seborrhea, androgenic alopecia. hirsutism, and breast cancer
10/21/2008US7439356 Substituted indan derivatives
10/21/2008US7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/21/2008US7438728 5-bromo-2-{(E)-[4-(dimethylamino)-2-hydroxyphenyl]diazenyl}-1-[3-(2-{(E)-[4-(dimethylamino)phenyl]diazenyl}pyridinium-1-yl)propyl]pyridinium dibromide; hair dye
10/21/2008CA2171334C Substituted thiazolo[3,2-a]azepine derivatives
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123017A1 Novel diamide derivative
10/16/2008WO2008122504A1 Alpha-hydroxyketones
10/16/2008WO2008030391A3 Difluorinated piperidines for treatment of alzheimer's disease and related conditions
10/16/2008WO2008011161A3 Dermal anesthetic compounds
10/16/2008WO2007121481A8 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
10/16/2008US20080255365 Microparticulate form of a Tetrahydropyridine derivative
10/16/2008US20080255362 Cyclic amide derivative, and its production and use
10/16/2008US20080255352 Cyclic amide derivative, and its production and use
10/16/2008US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255200 Benzimidazole enriched with deuterium; administering along with other active drugs
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255155 Inhibit protein tyrosine kinase; treating cell proliferative diseases and conditions; N-(6-(2-Fluoro-4-(4,4,4-trifluoro-3-(4-fluorophenylamino)butanamido)phenoxy)pyrimidin-4-yl)pyrrolidine-1-carboxamide
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255149 1-Oxopiperidine derivatives; amides derived from fused and/or spiro polyheterocycles such as decahydro-(iso)quinoline, tetrahydro(iso)quinoline, piperazine, piperidine, indole, or (iso)indole; histone deacetylase inhibitors; antiproliferative, antitumor, and antitumor agents; hyperplasia; immune diseases
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255124 4-[(Cyclopropylmethyl)(2-{[4-(1,1-dimethylethyl)phenyl]oxy}ethyl)amino]-2-(trifluoromethyl)benzonitrile; modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors; osteoporosis, muscle wasting,endometriosis, cardiovascular disease; breast, uterine cancer, prostatic hyperplasia
10/16/2008US20080255089 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; substituted 2-(p-aminoalkoxyphenyl)-1,1-diphenylethylene derivatives
10/16/2008US20080255083 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds
10/16/2008US20080251169 Ionic liquid, a method of synthesizing an ionic liquid, a precursor of an explosive composition including at least one ionic liquid, and a method of desensitizing an explosive composition
10/16/2008DE102007017884A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1979319A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
10/15/2008EP1979318A1 Amido compounds and their use as pharmaceuticals
10/15/2008EP1979311A2 Phenoxy acetic acids as ppar delta activators
10/15/2008EP1978959A2 Piperidine and piperazine derivatives
10/15/2008EP1978919A2 Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions
10/15/2008EP1685105B1 Allosteric modulators of metabotropic glutamate receptors
10/15/2008EP1641771B1 Hydroxamate sulfonamides as cd23 shedding inhibitors
10/15/2008EP1537081B1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
10/15/2008CN101287734A 2-氨基-7,8-二氢-6H-吡啶并[4,3-d]嘧啶-5-酮 2-amino-7,8-dihydro--6H- pyrido [4,3-d] pyrimidin-5-one
10/15/2008CN101287726A Pyrrolidine and piperidine acetylene derivatives for use as MGLUR5 antagonists
10/15/2008CN101287702A N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435747 Guanidine and amidine derivatives as factor Xa inhibitors
10/14/2008US7435746 4-{2-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-6-oxo-piperidin-1-yl]-ethylsulfanyl}-butyric acid or the methyl ester; glaucoma, intraocular hypotensive agents
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008CA2419279C Prodrugs to nmda receptor ligands
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2333089C Processes and intermediates for preparing 2-substituted piperidine stereoisomers
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof
10/09/2008WO2008119721A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119717A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008060621A3 Aminopyrrolidines as chemokine receptor antagonists
10/09/2008WO2007124424A3 Il-8 receptor antagonists
10/09/2008US20080249308 Complexes of Ruthenium with 2-(Aminomethyl)Pyridines and Phosphines, their Preparation and Use as Catalysts
10/09/2008US20080249132 Piperidine Carboxyamide Derivate Suitable as Tachykinin Receptor Antagonist
10/09/2008US20080249111 Piperdine Derivatives as CCR5 Inhibitors
10/09/2008US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol
10/08/2008EP1978017A1 Nitroxyl compound, and polymerization inhibitor and polymerization inhibitor composition using same
10/08/2008EP1978012A1 Alternative synthesis of renin inhibitors and intermediates thereof
10/08/2008EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
10/08/2008EP1976828A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008CN101282932A Carboxyamine compounds and their use in the treatment of HDAC dependent diseases
10/08/2008CN101282928A Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
10/08/2008CN100424075C Method for separating cis-3,5-dimethylpiperidine from a mixture of its geometrical isomers
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432378 For example, 2-{2-Chloro-4-[3-(4-methyl-piperazin-1-yl)-propoxy]-phenyl}-4,5-dimethyl-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432284 Estrogen receptor modulators
10/07/2008US7432283 Heterocyclic GABAA subtype selective receptor modulators
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008US7432280 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7431944 One-a-day, oral administration of a methylphenidate drug, e,g, Ritalin, the dosage of which form provides an immediate dose upon ingestion followed by release of more dose(s) later; particles uncoated/coated with ammonio methacrylate
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2201130C Process for the preparation of 3,3,5-trichloroglutarimide
10/02/2008WO2008117861A1 Intraocular pressure lowering agents containing phenylenediamine derivatives as the active ingredient
10/02/2008WO2008117123A2 Process for preparing donepezil hydrochloride polymorphic form i
10/02/2008WO2008116845A1 Piperidinone carboxamide derivatives as p2x7 modulators
10/02/2008WO2008019196A3 Carbometallation of alkynes and improved synthsis of ubiquinones
10/02/2008US20080242867 Recrystallization of phthaloylamlodipine from acetone and further cooling provides an acetone solvate of phthaloylamlodipine with high purity and yield
10/02/2008US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008CA2682221A1 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
10/01/2008EP1975153A2 Protease inhibitors
10/01/2008EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/01/2008EP1973878A1 Process and intermediate for preparation of donepezil
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 380